Intravesical N-(4-hydroxyphenyl) retinamide and Adriamycin induces apoptosis in bladder cancer

Frontiers in Bioscience

Volumn 11, Issue SUPPL. 1, 2006, Pages 2045-2051

  Qian, Lixin ^a   Ding, Hong ^b   Zhou, Jianwei ^a   Wang, Xinru ^a   Shao, Pengfei ^a   Wu, Shen ^a   Yang, Jie ^a   Feugang, Jean M ^c   Zou, Changping ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

4 HPR; Animal; Bladder; Cancer; Carcinoma; Chemical induced; Induction; Neoplasia; Retinoid; Tumor; Urinary tract

Indexed keywords

ANIMALIA; RATTUS NORVEGICUS;

EID: 33744751500     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1946     Document Type: Article

References (31)

1. Cohen, S.M., Shirai, T., and Steineck, G. Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol Suppl. 205, 105-115. (2000)
2. Atlanta, G.A. Cancer facts and figures. American Cancer Societ. 95, 234-240 (1995)
3. Jianjun, Zhang, Zhenbin, Fan, Vanning, Gao, Zejun, Xiao, Changling, Li, Qian, and Shujun, Cheng. Detecting Bladder Cancer in the Chinese by Microsatellite Analysis: Ethnic and Etiologic Considerations. JNCI 93, 45-51 (2001)
4. Verma AK. Retinoids in chemoprevention of cancer. J Biol Regul Homeost Agents 17, 92-97 (2003)
5. Camacho LH. Clinical applications of retinoids in cancer medicine. J Biol Regul Homeost Agents 17, 98-114 (2003)
6. Studer, U.E., Biedermann, C., Chollet, D., Karrer, P., Kraft, R., Toggenbutg, H., and Vonbank, F. Prevention of recurrent superficial bladder tumors by oral etretinate: preliminary results of a randomized, double blind multicenter trial in Switzerland. J Urol 131, 47-50 (1984)
7. Pedersen, H., Wolf, H., Kromann Jensen, S., lund, F., Hansen, E., Olsen, P. R., and Sorensen, B. L. Administration of retinoid as prophylasix of recurrent non-invasive bladder tumors. Scand J Urol Nephrol 18, 121-126 (1984)
8. Prout, G.R., and Barton, B.A. 13-cis-retinoic acid in chemoprevention of superficial bladder cancer. J Cell Biochem 161, 148-154 (1992)
9. Kelloff, G.J. N-(4-hydroxyphenyl)retinamide (4HPR): Clinical Development Plan. J Cell Biochem. Suppl 20, 176-196 (1994)
10. Tradati, N., Chiesa, F., Rossi, N., Grigolato, R., Formell, F., Costa, A., and De Palo, G. Successful topical treatment of oral lichen planus and leukoplakias with fenretinide (4-HPR). Cancer Lett 76, 109-111 (1994)
11. Modiano, M.R., Dalton, W.S., Lippman, S.M., Joffe, L., Booth, A.R., and Meyskens, F.L. Phase II study of fenretinide N-(4-hydroxyphenyl)retinamide) in advanced breast cancer and melanoma. Invest New Drugs 8, 317-319 (1990)
12. Zou, C. P., Kurie, J.M., Lotan, D., Zou, C.C., Hong, W.K., and Lotan, R. N-(4-Hydroxyphenyl) Retinamide (4HPR) induces apoptosis in human non-small cell lung cancer (NSCLC) cell lines. Clin Cancer Res 4, 1345-1355 (1998)
13. Pollard, M., Luckert, P.H., and Sporn, M.B. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide. Cancer Res 51, 3610-3611 (1991)
14. Decensi, A., Bruno, S., Giaretti, W., Torrisi, R., Curotto, A., Gatteschi, B., Geido, E., Polizzi, A., Costantini, M., Bruzzi, P., Nicolo, G., Costa, A., Boccardo, F., Giuliani, L., and Santi, L. Activity of 4-HPR in superficial bladder cancer using DNA flow cytometry as an intermediate endpoint. J Xell Biochem 161 (Suppl.), 139-147 (1992)
15. Zou, C.P., Liebert, M., Zou, C.C., Grossman, H.B., and Lotan, R. Identification of effective retinoids for inhibition growth and inducing apoptosis in bladder cancer cells. J of Urol 165, 986-992 (2001)
16. Kurth, K., and Tunn, U. Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: Long term results of a EORTC randomized trial comparing doxorubicin, ethoglucid and TUR alone. J of Urol 158, 378-384 (1997)
17. Steinberg, G.D., Brendler, C.B., Ichikawa, T., Squire, R. A., and Isaacs, J.T. Characterization of an N-methyl-N-nitrosourea-induced autochthonous rat bladder cancer model. Cancer Res 50, 6668-6674 (1990)
18. Hasegawa, R., Futakuchi, M., Mizoguchi, Y., Yamaguchi, T., Shirai, T., Ito, N., Lijinsky, W. Studies of initiation and promotion of carcinogenesis by N-nitroso compounds. Cancer Let 123, 185-191 (1998)
19. Elsasser-Beile, U., Ruhnau, T., Freudenberg, N., Wetterauer, U., and Mengs, U. Antitumoral effect of recombinant mistletoe lectin on chemically induced urinary bladder carcinogenesis in a rat model. Cancer 91, 998-1004 (2001)
20. Landis, S. H., Murray, T., Bolden, S., and Wingo, P.A. Cancer Statistics. CA Cancer J Clin 49, 8-31 (1999)
21. Morgan, D.t., Bowsher, W., Griffiths, D.F.R., and Matthews, P.N. Rationalisation of follow-up in patients with non-invasive bladder tumors. A preliminary report. Br J of Urol 67, 158-161 (1991)
22. Heney, N.M., Ahmed, S., Flanagan, M.J., Frable, W., Corder, M.P., Hafermann, M.D., and Hawkins, I.R. National bladder collaborative group A: superficial bladder cancer: progression and recurrence. J of Urol 130, 1083-1086 (2002)
23. Kurth, K.H., Bouffioux, C., Sylvester, R., Van der Meijden, A.P.M., Oosterlinck, W., Braus, M. Treatment of superficial bladder tumors: achiements and needs. Eur J Uro 37, 1-9 (2000)
24. Studer, U. E., Biedermann, C., Chollet, D., Karrer, P., Kraft, R., Toggenbutg, H., and Vonbank, F. Prevention of recurrent superficial bladder tumors by oral etretinate: preliminary results of a randomized, double blind multicenter trial in Switzerland. J of Urol 131, 47 (1984)
25. Studer, U. E., Jenzer, S., Biedermann, C., Chollet, D., Kraft, R., and Von Toggenburg, H. Adjuvant treatment with vitamin A analogue (etretinate) after transurethral resection of superficial bladder tumors. Final analysis of a prospective, randomized multi-center trial in Switzerland. Eur J Urol 28, 284-290 (1995)
26. Pedersen, H., Wolf, H., Kromann Jensen, S., Iund, F., Hansen, E., Olsen, P. R., and Sorensen, B. L. Administration of retinoid as prophylasix of recurrent non-invasive bladder tumors. Scand J Urol Nephrol 18, 121 (1984)
27. Prout, G.R., and Barton, B.A. 13-cis-retinoic acid in chemoprevention of superficial bladder cancer. J Cell Biochem supp 161, 148-158 (1992)
28. Hill, D.L. Retinoids and cancer prevention. Annu Rev Nutr 12, 161-181 (1992)
29. Kakizoe, T. Chemoprevention of cancer focusing on clinical trials. Japan J of Clin Onco 33, 421-442 (2003)
30. Lippman, S.M., and Lotan, R. Advances in the Development of Retinoids as Chemopreventive Agents. J Nutrition 130, 49-54 (2000)
31. Decensis, A., Torrisi, R., Bruno, R., Costantini, M., Curotto, A., Nicolò, A., Malcangi, B., Baglietto, L., Bruttini, G.P., Gatteschi, B., Rondanina, G., Varaldo, M., Perloff, M., Malone W.F., and Bruzzi, P. Randomized Trial of Fenretinide in Superficial Bladder Cancer Using DNA Flow Cytometry as an Intermediate End Point. Cancer Epi Biomaker Prevention 9, 1071-1078 (2000)